分次剂量肠道准备对息肉检出效力的系统评价与Meta分析
该系统评价与Meta分析检索截至2017年6月的随机对照试验,纳入28项试验共8842名参与者,比较分次剂量与前一天、当天及不同分次方案对息肉检出的影响。分次剂量较前一天方案提高腺瘤、进展期腺瘤及无蒂锯齿状息肉检出率,与当天方案比较无统计学差异,不同分次方案间未发现更优方案。
要点
- 分次剂量较前一天方案提高腺瘤检出(RR 1.26,95%CI 1.10-1.44)。
- 分次剂量较前一天方案提高进展期腺瘤检出(RR 1.53,95%CI 1.22-1.92)。
- 分次剂量较前一天方案对无蒂锯齿状息肉检出获益最大(RR 2.48,95%CI 1.21-5.09)。
核心结论
- 与前一天肠道准备方案相比,分次剂量肠道准备方案提高腺瘤和进展期腺瘤的检出,并在无蒂锯齿状息肉检出上获益最大。
研究设计与样本
- 系统评价与Meta分析,检索MEDLINE、EMBASE和CENTRAL数据库(从建库至2017年6月)的随机对照试验。
- 纳入28项试验,共8842名参与者;排除仅限于住院患者、儿童或炎症性肠病患者的研究。
主要发现
- 7项试验比较分次剂量与前一天方案,腺瘤检出率升高(RR 1.26,95%CI 1.10-1.44;4项试验;1258名参与者)。
- 分次剂量较前一天方案提高进展期腺瘤检出(RR 1.53,95%CI 1.22-1.92;3项试验;1155名参与者)。
- 分次剂量较前一天方案提高无蒂锯齿状息肉检出(RR 2.48,95%CI 1.21-5.09;2项试验;1045名参与者)。
- 8项试验(1587名参与者)比较分次剂量与当天方案,汇总估计无统计学差异的证据。
- 14项试验(5496名参与者)比较不同分次剂量方案,未发现更优的分次方案。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Split-dose bowel preparation leads to superior colon cleansing for colonoscopy. However, the magnitude of benefit in detecting colonic polyps is uncertain. We performed a systematic review to synthesize the data on whether using a split-dose bowel preparation regimen improves the detection of polyps when compared with other dosing methods or regimen products. METHODS: We searched MEDLINE, EMBASE, and CENTRAL databases (from the inception to June 2017) for randomized controlled trials that assessed the following: split-dose vs day-before, split-dose vs same-day (as colonoscopy), or different types of split-dose regimens for patients undergoing colonoscopy. We excluded studies limited to inpatients, children, or individuals with inflammatory bowel disease. We compared the number of patients undergoing colonoscopy with recorded detection of polyps, adenomas, advanced adenomas, sessile serrated polyps (SSPs), right colonic adenomas, right colonic polyps, or right colonic SSPs. RESULTS: Twenty-eight trials fulfilled the inclusion criteria (8,842 participants). Of the seven trials comparing split-dose vs day-before bowel preparation regimens, there was an increased detection rate of adenomas (risk ratio (RR) 1.26, 95% confidence intervals (CIs): 1.10-1.44; 4 trials; 1,258 participants), advanced adenomas (RR 1.53, 95% CI: 1.22-1.92; 3 trials; 1,155 participants), and SSPs (RR 2.48, 95% CI: 1.21-5.09; 2 trials; 1,045 participants). Pooled estimates from 8 trials (1,587 participants) evaluating split-dose vs same-day bowel preparations yielded no evidence of statistical difference. For various split-dose vs split-dose trials, 14 fulfilled the criteria (5,496 participants) and no superior split-regimen was identified. CONCLUSIONS: Compared with day-before bowel preparation regimens, split-dose bowel preparations regimens increase the detection of adenomas, advanced adenomas, and have the greatest benefit in SSP detection.
引用
- Zawaly K, Rumbolt C, Abou-Setta AM, et al. The Efficacy of Split-Dose Bowel Preparations for Polyp Detection: A Systematic Review and Meta-Analysis. Am J Gastroenterol. 2019. PMID: 30865011. doi:10.14309/ajg.0000000000000155
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。